Balance Sheet - Bicara Therapeutics Inc. (BCAX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | |
|---|---|---|---|---|
| Total cash and short-term investments | 414.80 | 489.71 | 230.44 | 4.16 |
| Other current assets | 7.25 | 12.82 | 0.63 | 0.83 |
| Total current assets | 422.05 | 502.53 | 231.07 | 4.98 |
| Total non-current assets | 8.94 | 66.66 | 2.91 | 1.72 |
| Total assets | 430.99 | 569.20 | 233.98 | 6.70 |
| Total current liabilities | 28.95 | 17.99 | 15.09 | 23.90 |
| Total non-current liabilities | 0.59 | 59.33 | 0.39 | 0.09 |
| Total liabilities | 29.54 | 77.32 | 15.47 | 23.98 |
| Total stockholders' equity | 401.45 | 491.88 | 218.51 | -17.28 |
| Common shares outstanding | 55 | 54 | 52 | 52 |
Show Quarterly Balance Sheet
Balance Sheet - Bicara Therapeutics Inc. (BCAX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 539.75 | 414.80 | 290.17 | 436.61 | 462.07 | 489.71 | 520.76 | 203.86 | 203.86 | 230.44 | 0.00 | 0.00 | 4.16 |
| Other current assets | 5.16 | 7.25 | 7.21 | 7.79 | 8.69 | 12.82 | 0.76 | 2.22 | 2.22 | 0.63 | -4.16 | ||
| Total current assets | 544.92 | 422.05 | 297.37 | 444.39 | 470.75 | 502.53 | 521.51 | 206.08 | 206.08 | 231.07 | 4.16 | ||
| Total non-current assets | 8.68 | 8.94 | 127.32 | 9.20 | 7.32 | 66.66 | 2.66 | 2.71 | 2.71 | 2.91 | -4.16 | ||
| Total assets | 553.60 | 430.99 | 424.69 | 453.59 | 478.08 | 569.20 | 524.17 | 208.78 | 208.78 | 233.98 | |||
| Total current liabilities | 39.34 | 28.95 | 21.03 | 17.23 | 19.12 | 17.99 | 14.48 | 16.07 | 16.07 | 15.09 | |||
| Total non-current liabilities | 0.30 | 0.59 | 0.88 | 1.16 | 0.00 | 59.33 | 0.14 | 367.49 | 0.22 | 0.39 | 17.28 | ||
| Total liabilities | 39.64 | 29.54 | 21.91 | 18.39 | 19.12 | 77.32 | 14.62 | 383.56 | 16.28 | 15.47 | 17.28 | ||
| Total stockholders' equity | 513.96 | 401.45 | 402.78 | 435.20 | 458.96 | 491.88 | 509.56 | -174.78 | 192.50 | 218.51 | -17.28 | ||
| Common shares outstanding | 61 | 55 | 55 | 55 | 54 | 54 | 54 | 54 | 54 | 53 | 54 | 55 | 55 |